Table of Contents Author Guidelines Submit a Manuscript
Radiology Research and Practice
Volume 2016 (2016), Article ID 8792984, 10 pages
http://dx.doi.org/10.1155/2016/8792984
Research Article

Contrast Induced Nephropathy with Intravenous Iodinated Contrast Media in Routine Diagnostic Imaging: An Initial Experience in a Tertiary Care Hospital

1Department of Radiodiagnosis, University College of Medical Sciences and GTB Hospital, Dilshad Garden, Delhi 110095, India
2Department of Medicine, University College of Medical Sciences and GTB Hospital, Dilshad Garden, Delhi 110095, India

Received 17 November 2015; Revised 23 January 2016; Accepted 2 February 2016

Academic Editor: Sotirios Bisdas

Copyright © 2016 Shuchi Bhatt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Nash, A. Hafeez, and S. Hou, “Hospital-acquired renal insufficiency,” American Journal of Kidney Diseases, vol. 39, no. 5, pp. 930–936, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Mehta, J. A. Kellum, S. V. Shah et al., “Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury,” Critical Care, vol. 11, article R31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Gruberg, R. Mehran, G. Dangas et al., “Acute renal failure requiring dialysis after percutaneous coronary interventions,” Catheterization and Cardiovascular Interventions, vol. 52, no. 4, pp. 409–416, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. P. A. McCullough, A. Adam, C. R. Becker et al., “Epidemiology and prognostic implications of contrast-induced nephropathy,” The American Journal of Cardiology, vol. 98, no. 6, supplement 1, pp. 5–13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. H. S. Thomsen and S. K. Morcos, “Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines,” British Journal of Radiology, vol. 76, no. 908, pp. 513–518, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. C. S. Rihal, S. C. Textor, D. E. Grill et al., “Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention,” Circulation, vol. 105, no. 19, pp. 2259–2264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. P. A. McCullough, R. Wolyn, L. L. Rocher, R. N. Levin, and W. W. O'Neill, “Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality,” The American Journal of Medicine, vol. 103, no. 5, pp. 368–375, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Mitchell, A. E. Jones, J. A. Tumlin, and J. A. Kline, “Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 1, pp. 4–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. J. McDonald, J. S. McDonald, J. P. Bida et al., “Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?” Radiology, vol. 267, no. 1, pp. 106–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Berns, “Nephrotoxicity of contrast media,” Kidney International, vol. 36, no. 4, pp. 730–740, 1989. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kolonko, F. Kokot, and A. Wiecek, “Contrast-associated nephropathy—old clinical problem and new therapeutic perspectives,” Nephrology Dialysis Transplantation, vol. 13, no. 3, pp. 803–806, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. S. T. Cochran, W. S. Wong, and D. J. Roe, “Predicting angiography-induced acute renal function impairment: clinical risk model,” American Journal of Roentgenology, vol. 141, no. 5, pp. 1027–1033, 1983. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Rudnick, J. S. Berns, R. M. Cohen, and S. Goldfarb, “Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism—a critical review,” American Journal of Kidney Diseases, vol. 24, no. 4, pp. 713–727, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Mehran, E. D. Aymong, E. Nikolsky et al., “A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation,” Journal of the American College of Cardiology, vol. 44, no. 7, pp. 1393–1399, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” American Journal of Kidney Diseases, vol. 39, no. 2, supplement 1, pp. S1–S266, 2002. View at Google Scholar
  16. R. J. Owen, S. Hiremath, A. Myers, M. Fraser-Hill, and B. Barrett, “Consensus guidelines for the the prevention of contrast induced nephropathy,” Canadian Association of Radiologists Journal, vol. 58, no. 2, pp. 79–57, 2007. View at Google Scholar
  17. American Diabetes Association, “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 20, no. 7, pp. 1183–1197, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of high blood pressure: the JNC 7 report,” The Journal of the American Medical Association, vol. 289, pp. 2560–2572, 2003. View at Google Scholar
  19. WHO, UNICEF, and UNU, Iron Deficiency Anaemia: Assessment, Prevention and Control, a Guide for Programme Managers, World Health Organization, Geneva, Switzerland, 2001.
  20. N. Abramson and B. Melton, “Leukocytosis: basics of clinical assessment,” American Family Physician, vol. 62, no. 9, pp. 2053–2060, 2000. View at Google Scholar · View at Scopus
  21. B. M. Elicker, Y. S. Cypel, and J. C. Weinreb, “IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy,” American Journal of Roentgenology, vol. 186, no. 6, pp. 1651–1658, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Davidson, F. Stacul, P. A. McCullough et al., “Contrast medium use,” American Journal of Cardiology, vol. 98, supplement 1, no. 6, pp. 42–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. S. Waikar and J. V. Bonventre, “Creatinine kinetics and the definition of acute kidney injury,” Journal of the American Society of Nephrology, vol. 20, no. 3, pp. 672–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Bruce, A. Djamali, K. Shinki, S. J. Michel, J. P. Fine, and M. A. Pozniak, “Background fluctuation of kidney function versus contrast-induced nephrotoxicity,” American Journal of Roentgenology, vol. 192, no. 3, pp. 711–718, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. W. Katzberg, “Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity,” Radiology, vol. 204, no. 2, pp. 297–312, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. T. G. Gleeson and S. Bulugahapitiya, “Contrast-induced nephropathy,” American Journal of Roentgenology, vol. 183, no. 6, pp. 1673–1689, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. P. P. Leyssac, N.-H. Holstein-Rathlou, and O. Skøtt, “Renal blood flow, early distal sodium, and plasma renin concentrations during osmotic diuresis,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 279, no. 4, pp. R1268–R1276, 2000. View at Google Scholar · View at Scopus
  28. J. Tumlin, F. Stacul, A. Adam et al., “Pathophysiology of contrast-induced nephropathy,” The American Journal of Cardiology, vol. 98, no. 6, pp. 14K–20K, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. D. Moore, E. P. Steinberg, N. R. Powe et al., “Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial,” Radiology, vol. 182, no. 3, pp. 649–655, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. J. S. McDonald, R. J. McDonald, R. E. Carter, R. W. Katzberg, D. F. Kallmes, and E. E. Williamson, “Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate,” Radiology, vol. 271, no. 1, pp. 65–73, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. L. A. Hayman, “Contrast-induced renal failure,” Radiology, vol. 137, pp. 867–869, 1980. View at Google Scholar
  32. E. M. Levy, C. M. Viscoli, and R. I. Horwitz, “The effect of acute renal failure on mortality: a cohort analysis,” The Journal of the American Medical Association, vol. 275, no. 19, pp. 1489–1494, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. P. A. McCullough, F. Stacul, C. R. Becker et al., “Contrast-induced nephropathy (CIN) consensus working panel: executive summary,” Reviews in Cardiovascular Medicine, vol. 7, no. 4, pp. 177–197, 2006. View at Google Scholar
  34. O. Toprak and M. Cirit, “Risk factors and therapy strategies for contrast induced nephropathy,” Renal Failure, vol. 28, no. 5, pp. 365–381, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Goldenberg and S. Matetzky, “Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies,” Canadian Medical Association Journal, vol. 172, no. 11, pp. 1461–1471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Mehran and E. Nikolsky, “Contrast-induced nephropathy: definition, epidemiology and patients at risk,” Kidney International, vol. 69, pp. S11–S15, 2006. View at Google Scholar · View at Scopus
  37. S. Evola, M. Lunetta, F. Macaione et al., “Risk factors for contrast induced nephropathy: a study among italian patients,” Indian Heart Journal, vol. 64, no. 5, pp. 484–491, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. E. Gussenhoven, J. Ravensbergen, J. H. van Bockel, J. D. M. Feuth, and J. C. N. M. Aarts, “Renal dysfunction after angiography; a risk factor analysis in patients with peripheral vascular disease,” Journal of Cardiovascular Surgery, vol. 32, no. 1, pp. 81–86, 1991. View at Google Scholar · View at Scopus
  39. A. S. Kini, C. A. Mitre, M. Kim, M. Kamran, D. Reich, and S. K. Sharma, “A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam,” Catheterization and Cardiovascular Interventions, vol. 55, no. 2, pp. 169–173, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. B. J. Barrett and P. S. Parfrey, “Prevention of nephrotoxicity induced by radiocontrast agents,” The New England Journal of Medicine, vol. 331, no. 21, pp. 1449–1450, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. O. Miettnen, “Design options in epidemiologic research. An update,” Scandinavian Journal of Work, Environment & Health, vol. 8, supplement 1, pp. 7–14, 1982. View at Google Scholar
  42. M. R. Rudnick, J. S. Berns, R. M. Cohen, and S. Goldfarb, “Contrast media-associated nephrotoxicity,” Seminars in Nephrology, vol. 17, no. 1, pp. 15–26, 1997. View at Google Scholar · View at Scopus
  43. K. A. Hall, R. W. Wong, G. C. Hunter et al., “Contrast-induced nephrotoxicity: the effects of vasodilator therapy,” Journal of Surgical Research, vol. 53, no. 4, pp. 317–320, 1992. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Trivedi and W. D. Foley, “Contrast-induced nephropathy after a second contrast exposure,” Renal Failure, vol. 32, no. 7, pp. 796–801, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. H. H. Abujudeh, M. S. Gee, and R. Kaewlai, “In emergency situations, should serum creatinine be checked in all patients before performing second contrast CT examinations within 24 hours?” Journal of the American College of Radiology, vol. 6, no. 4, pp. 268–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. E. M. Lautin, N. J. Freeman, A. H. Schoenfeld et al., “Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media,” American Journal of Roentgenology, vol. 157, no. 1, pp. 59–65, 1991. View at Publisher · View at Google Scholar · View at Scopus
  47. Contrast-Induced Nephrotoxicity, ACR Manual on Contrast Media 2013, 9th edition, 2013, http://geiselmed.dartmouth.edu/radiology/pdf/ACR_manual.pdf.
  48. B. J. Barrett, “Contrast nephrotoxicity,” Journal of the American Society of Nephrology, vol. 5, no. 2, pp. 125–137, 1994. View at Google Scholar · View at Scopus
  49. E. Nikolsky, R. Mehran, D. Turcot et al., “Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention,” The American Journal of Cardiology, vol. 94, no. 3, pp. 300–305, 2004. View at Publisher · View at Google Scholar · View at Scopus